Market Place
Sourcing Support
NICE does not recommend elosulfase alfa for Morquio A syndrome
16 Nov 2021 //
EUROPEANPHARMACEUTICALREVIEW
BioMarin`s Vimizim (elosulfase alfa) Receives Supplemental Approval in US
04 Dec 2019 //
FDA
BioMarin Announces Approval of Vimizim
04 Jun 2019 //
PR NEWSWIRE
BioMarin investing $43M in fill-finish line at plant in Ireland
04 Sep 2018 //
FIERCE PHARMA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.